Patent ID: 11890335
Assignee: L2 DIAGNOSTICS, LLC
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C  Y | IPC A

Claim 10:
11. The pharmaceutical composition of claim 10, wherein:
(i) the TLR is TLR3, and the at least one receptor agonist of a TLR is a TLR3 agonist that is polyLC;
(ii) the TLR is TLR4, and the at least one receptor agonist of a TLR is a TLR4 agonist that is MPL;
(iii) the TLR is TLR7, and the at least one receptor agonist of a TLR is a TLR7 agonist that is R848; and/or
(iv) the TLR is TLR9, and the at least one receptor agonist of a TLR is a TLR9 agonist that is CpG.